Separately, Zacks Investment Research cut Fanhua from a buy rating to a hold rating in a report on Tuesday, March 1st.
Shares of NASDAQ FANH opened at $6.30 on Monday. The stock has a market cap of $338.28 million, a price-to-earnings ratio of 8.87 and a beta of 0.54. Fanhua has a 1-year low of $6.01 and a 1-year high of $16.00. The stock’s 50-day moving average is $6.90 and its 200 day moving average is $9.23.
A number of institutional investors have recently made changes to their positions in FANH. BlackRock Inc. increased its stake in shares of Fanhua by 0.8% during the fourth quarter. BlackRock Inc. now owns 1,012,332 shares of the financial services provider’s stock valued at $7,371,000 after buying an additional 8,214 shares during the period. Marshall Wace LLP purchased a new position in shares of Fanhua during the fourth quarter valued at approximately $663,000. Canada Pension Plan Investment Board increased its stake in shares of Fanhua by 106.1% during the fourth quarter. Canada Pension Plan Investment Board now owns 97,110 shares of the financial services provider’s stock valued at $707,000 after buying an additional 50,000 shares during the period. Citadel Advisors LLC purchased a new position in shares of Fanhua during the fourth quarter valued at approximately $420,000. Finally, Nuveen Asset Management LLC increased its stake in shares of Fanhua by 7.1% during the fourth quarter. Nuveen Asset Management LLC now owns 43,626 shares of the financial services provider’s stock valued at $318,000 after buying an additional 2,900 shares during the period. 23.98% of the stock is currently owned by institutional investors and hedge funds.
About Fanhua (Get Rating)
Fanhua Inc, together with its subsidiary, distributes insurance products in China. It operates through two segments, Insurance Agency and Claims Adjusting. The Insurance Agency segment provides property and casualty insurance products that primarily include individual accident, travel, homeowner, and indemnity medical insurance products; and life insurance products, such as individual health, individual whole life, individual term life, individual endowment life, and individual annuity, as well as participating insurance products.
- Get a free copy of the StockNews.com research report on Fanhua (FANH)
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Ross Stores On The Verge Of Major Rally
- Insiders Are Selling Palo Alto Networks
Receive News & Ratings for Fanhua Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fanhua and related companies with MarketBeat.com's FREE daily email newsletter.